IMPPAT Phytochemical information: 
Glycyrrhizic acid

Glycyrrhizic acid
Clinical trials
Public title (as per ICTRP)Scientific title (as per ICTRP)Trial identifier
Exploratory Clinical Study on the Effectiveness of Glycyrrhizin in Early Vascular Lesions of Systemic SclerosisExploratory Clinical Study on the Effectiveness of Glycyrrhizin in Early Vascular Lesions of Systemic Sclerosis - The Effectiveness of Glycyrrhizin in Systemic SclerosisJPRN-UMIN000032238
Effacacy of compound glycyrrhizin in gemcitabine accociated rash and abnormal liver function: a randomized controlled, phase II studyEffacacy of compound glycyrrhizin in gemcitabine accociated rash and abnormal liver function: a randomized controlled, phase II studyChiCTR-IIR-17012919
Entecaver adding 18a-glycyrrhizin to reverse the cirrhosis in the chronic hepatitis patientEntecaver adding 18a-glycyrrhizin to reverse the cirrhosis in the chronic hepatitis patientChiCTR-IPR-16009493
Effect of glycyrrhizic acid on the pharmacokinetics of talinololEffect of glycyrrhizic acid on the pharmacokinetics of talinololChiCTR-RRC-10000999
Efficacy and safety of Compound Glycyrrhizin Capsules in patients with localized chronic eczema: a multi-center, randomized, double blind, placebo controlled clinical trialEfficacy and safety of Compound Glycyrrhizin Capsules in patients with localized chronic eczemaChiCTR-IPR-17011511
GU-01: Glycyrrhizin in Prostate CancerGU-01: Glycyrrhizin in Prostate Cancer: a Window-of-Opportunity TrialNCT06378346
Treatment of mild to moderate alopecia areata with compound glycyrrhizin: a randomized controlled trialTreatment of mild to moderate active alopecia areata with compound glycyrrhizin: a randomized controlled trialChiCTR1800018691
Multi-center, randomized, double-blind, controlled clinical efficacy observation of compound glycyrrhizin tablets in the treatment of childhood asthma and its regulation on Th17 / Treg signaling pathwayMulti-center, randomized, double-blind, controlled clinical efficacy observation of compound glycyrrhizin tablets in the treatment of childhood asthma and its regulation on Th17 / Treg signaling pathwayChiCTR2000032644
Compound glycyrrhizin protects against vancomycin-induced acute kidney injury: a cohort studyCompound glycyrrhizin protects against vancomycin-induced acute kidney injury: a cohort studyChiCTR2400094905
Compound glycyrrhizin regulates macrophage polarization by inhibiting HMGB1 to resist abnormal immune response in vitiligoCompound glycyrrhizin regulates macrophage polarization by inhibiting HMGB1 to resist abnormal immune response in vitiligoChiCTR2400086844
To compare therapeutic effect of Glycyrrhizic Acid and H1-receptor antagonist for acute urticaria : a multicenter, prospective, single-blind, randomized controlled trialTo compare therapeutic effect of Glycyrrhizic Acid and H1-receptor antagonist for acute urticaria : a multicenter, prospective, single-blind, randomized controlled trial - To compare therapeutic effect of Glycyrrhizic Acid and H1-receptor antagonist for acute urticaria : a multicenter, prospective, single-blind, randomized controlled trialJPRN-UMIN000001254
Clinical Observation of Long-term Efficacy and Safety of Glycyrrhizic Acid Preparation in the Therapy of Autoimmune Liver DiseaseClinical Observation of Long-term Efficacy and Safety of Glycyrrhizic Acid Preparation in the Treatment of Autoimmune Liver DiseaseNCT04028869
A novel drug combination and route for COVID-19 treatmentThe use of topical (Nasal and oropharyngeal) Povidone iodine plus topical Glycyrrhizic acid and oral Glycyrrhizic acid syrup for prevention and treatment of early COVID-19 cases.PACTR202101875903773
Evaluation of the effect of glycyrrhizin hydrogel on laser burnsPreparation and evaluation of topical glycyrrhizin-menthol-aloe vera gel and assessment its effect on the prevention of laser-induced dermatitis: a randomized controlled clinical trialIRCT20191106045356N17